The 70% Scalp DHT Number: What Finasteride's Suppression Ceiling Means
Affiliate disclosure: This page contains affiliate links. We may earn a commission at no extra cost to you. Editorial content is independent.
Finasteride does not eliminate DHT — it reduces it. The 60–70% ceiling is clinically sufficient for most users and has a hard floor set by type 1 enzyme activity that no dose of finasteride will get below.
The phrase “finasteride reduces DHT by 70%” appears in most clinical summaries of the medication and is accurate as a round number. The precise figures from research range from approximately 60–70% for scalp DHT and 65–70% for serum DHT on standard 1mg daily oral dosing. Understanding why it stops there — and what the residual DHT means clinically — is worth being clear about.
Why the ceiling exists where it does
Finasteride inhibits 5-alpha-reductase type 2 with high selectivity. Type 2 is the predominant enzyme isoform in the hair follicle's dermal papilla cells. Blocking it removes most DHT production at the follicle level.
DHT is also produced by type 1 5-alpha-reductase activity in the liver, adrenal glands, and peripheral skin. This production continues essentially unaffected by finasteride. The DHT produced by type 1 enters circulation and distributes to the scalp, accounting for the 30–40% that persists despite finasteride use.
The floor is structural: set by type 1 activity that finasteride does not address. There is no dose of finasteride that gets below it. Higher doses of finasteride do not meaningfully extend type 1 inhibition — the dose-response curve flattens well below maximum possible suppression.
What happens clinically at the residual level
In men without genetic predisposition to AGA, even full DHT levels do not cause pattern hair loss. The mechanism requires both the androgen signal and genetic follicular sensitivity. For men with AGA, the question is how much DHT is required to continue driving miniaturisation.
The clinical answer in most cases: the residual 30–40% of DHT after finasteride is insufficient to drive miniaturisation at baseline rate, which is why most users see stabilisation or improvement. But it is not zero, which is why some users see continued slow progression on finasteride and why it rarely produces complete arrest in highly sensitive individuals.
What the research shows at the suppression ceiling
- ~66% of men see hair density improvement at 12 months on finasteride 1mg
- ~83% see improvement or stabilisation combined
- ~17% continue to progress despite treatment
The distribution reflects varying follicular sensitivity — follicles that miniaturise at lower DHT concentrations are more likely to progress at the 30–40% residual level that finasteride leaves.
The dutasteride option
Dutasteride inhibits both type 1 and type 2 5-AR, reducing serum DHT by approximately 90–95%. In head-to-head comparisons, dutasteride 0.5mg outperforms finasteride 1mg on hair count and density measures. For men who have reached the finasteride ceiling with documented non-response, dutasteride is the logical clinical next step.
The trade-off: longer half-life (five weeks versus six hours), deeper systemic DHT suppression, and much slower recovery if discontinued — relevant for fertility planning and side effect persistence. For first-time starters, finasteride remains appropriate first-line.
If you are in the 17%
A documented non-response to finasteride at 12 months means the residual DHT is sufficient to continue driving miniaturisation in your specific follicles. It is pharmacological and biological information, not a failure. The next step has options, and the conversation with a prescribing clinician is the right place to have it.
Common questions
Why doesn't finasteride reduce DHT by 100%?
Finasteride selectively inhibits 5-alpha-reductase type 2. Type 1 enzyme activity continues to produce DHT in the liver and peripheral skin. Eliminating all DHT requires blocking both isoforms — which dutasteride achieves, reaching approximately 90–95% suppression.
Is 60–70% DHT suppression enough to stop hair loss?
For the majority of men who respond to finasteride, yes. Clinical trials show meaningful hair density improvement in approximately 66% of users and stabilisation in most others. The residual DHT is insufficient to drive miniaturisation at baseline rate — but it does mean that progression continues at a reduced rate, not zero, in some users.
What if finasteride isn't suppressing enough DHT for me?
If clinical assessment at 12 months shows continued progression despite confirmed finasteride use, options include switching to dutasteride (deeper dual inhibition), adding topical agents, or combination protocols. A clinician familiar with hair loss can guide the workup.
References & further reading
- Drake L, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology, 1999.
- Clark RV, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride. Journal of Clinical Endocrinology and Metabolism, 2004.
Get your prescription
Care Bare Rx
Telehealth hair loss evaluation with licensed clinicians. Online intake, same-week prescriptions, and compounded finasteride or combination formulas shipped directly to your door.
Start Your Care Bare Rx Intake Paid linkSesame Care
Book directly with licensed physicians at transparent, upfront prices. FDA-approved brand-name and generic finasteride prescriptions, no insurance required, no membership fee.
Browse Sesame Care Providers Paid linkAbout compounded medications: Compounded drugs are prepared by a pharmacy for an individual patient and are not FDA-approved. The FDA does not review them for safety, effectiveness, or manufacturing quality. Discuss the trade-offs with a licensed prescriber before starting.
Affiliate Disclosure: This site earns commissions on referrals. Editorial content is independent. We only feature licensed, verified providers.
Medical disclaimer: This article is for general information only and does not constitute medical advice, diagnosis, or treatment. Finasteride is a prescription medication with a documented side effect profile. Always consult a licensed physician before starting, stopping, or changing any medication.